Here are the 424B prospectus supplements from Surrozen, Inc. (SRZN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow SRZN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SRZN filings page.
Surrozen, Inc. filed a prospectus to offer up to $50,000,000 of common stock through an at‑the‑market sales agreement with TD Securities (USA) LLC (TD Cowen). The company may sell shares from time to time on Nasdaq or other trading markets under the Sales Agreement dated March 23, 2026.
The prospectus states an assumed reference price of $25.15 per share (last reported sale price on March 20, 2026) and illustrates that up to 11,762,608 shares could be issued if the full $50,000,000 aggregate amount is sold at that price. Proceeds are intended for working capital and general corporate purposes, and TD Cowen may receive up to 3.0% of gross proceeds as compensation.